Is Credicorp Ltd (BAP) a risky stock?
As of July 29, 2026, Clavix grades Credicorp Ltd (BAP) A- for risk, a composite score of 82 out of 100 on an A+ to F scale, which puts BAP in the "low risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 29, 2026. Clavix regrades every trading day.
The five risk dimensions behind BAP's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how BAP scores on each, as of July 29, 2026.
What's moving BAP's risk right now
Company-specific signals Clavix flags behind BAP's current grade, drawn from recent news and filings as of July 29, 2026.
Credicorp enters a quiet period from July 30 to August 13 ahead of its Q2 2026 earnings release. Separately, WCM Investment Management trimmed its BAP holding. The August 13 earnings print is the next material catalyst.
Goldman lifted its Credicorp price target by 13.7% to $374.00 while keeping a neutral rating, suggesting the bank sees the stock as fairly valued after its recent run-up.
Krealo, Credicorp's venture capital arm, led a $5.2M seed round in Chilean fintech Blanco. The investment extends Credicorp's reach into Chile's fintech market through its CVC arm.
Recent BAP news
The latest headlines Clavix ingested for Credicorp Ltd, newest first. These feed the news-sentiment dimension of BAP's grade.
-
Credicorp announced it will enter a quiet period starting July 30, 2026, ahead of its Q2 2026 earnings release scheduled for August 13, in compliance with its corporate disclosure policies to prevent premature financial information leaks.
-
WCM Investment Management LLC reduced its holdings in Credicorp Ltd. (NYSE:BAP) by 8.1% during the first quarter, selling 23,031 shares and ending the period with 262,968 shares, according to its Form 13F filing.
What a A- grade means
On the Clavix A+ to F scale, BAP's composite of 82 falls in the A band (80–100), read as "low risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell BAP or any security. Grades are risk indicators, not predictions of return. Data may be delayed.